Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Two newer classes of drugs to treat adult-onset diabetes may be no more effective than the old standby, yet they cost significantly more over the course of a patient's disease.
That's according to a National Science Foundation-funded study by researchers at the University of Michigan, Mayo Clinic and North Carolina State University.
Based on a simulation model that involved 15 years worth of actual patient data from more than 37,000 individuals, the researchers found that the newer drugs cost patients and insurance companies anywhere from $1,600 to $2,400 more.
http://www.enewspf.com/latest-news/...-drugs-cost-more-but-may-not-work-better.html
That's according to a National Science Foundation-funded study by researchers at the University of Michigan, Mayo Clinic and North Carolina State University.
Based on a simulation model that involved 15 years worth of actual patient data from more than 37,000 individuals, the researchers found that the newer drugs cost patients and insurance companies anywhere from $1,600 to $2,400 more.
http://www.enewspf.com/latest-news/...-drugs-cost-more-but-may-not-work-better.html